Credit Suisse Ag Astrazeneca PLC Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $235,386 - $255,252	3,367 Added 5.95%	60,000 $4.29 Million
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $2.17 Million - $2.46 Million	-34,362 Reduced 37.76%	56,633 $3.93 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $1.22 Million - $1.58 Million	22,476 Added 32.8%	90,995 $6.17 Million
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $2.48 Million - $6.34 Million	-46,700 Reduced 40.53%	68,519 $3.76 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $662,289 - $795,060	11,176 Added 10.74%	115,219 $7.61 Million

Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $783,367 - $943,640	14,059 Added 15.62%	104,043 $6.9 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $13.8 Million - $16.3 Million	-255,070 Reduced 73.92%	89,984 $5.24 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $4.5 Million - $4.92 Million	80,988 Added 30.67%	345,054 $20.7 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $8.24 Million - $10.2 Million	170,085 Added 180.98%	264,066 $15.8 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $978,805 - $1.13 Million	-20,755 Reduced 18.09%	93,981 $4.67 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $4.26 Million - $5.09 Million	87,787 Added 325.75%	114,736 $5.74 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $3.81 Million - $4.38 Million	-71,700 Reduced 72.68%	26,949 $1.48 Million
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $4.25 Million - $5.46 Million	98,649 New	98,649 $5.22 Million
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $2.38 Million - $3.23 Million	-62,968 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$42.46 - $50.46 $2.05 Million - $2.44 Million	48,361 Added 331.08%	62,968 $3.14 Million
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $2.57 Million - $2.91 Million	-63,996 Reduced 81.42%	14,607 $651,000
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $1.29 Million - $1.44 Million	-34,625 Reduced 30.58%	78,603 $3.25 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $4.02 Million - $4.87 Million	113,228 New	113,228 $4.58 Million
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $695,658 - $783,040	-18,873 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $278,879 - $318,673	8,023 Added 73.94%	18,873 $746,000
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $1.25 Million - $1.34 Million	-36,157 Reduced 76.92%	10,850 $381,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $458,678 - $509,596	13,912 Added 42.04%	47,007 $1.64 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $204,734 - $221,896	6,380 Added 23.88%	33,095 $1.15 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $773,666 - $908,310	26,715	26,715 $905,000

Others Institutions Holding AZN

# of Institutions

1,541

Shares Held

503M

Call Options Held

5.59M

Put Options Held

3.18M

Price T Rowe Associates Inc Baltimore, MD

49.1M
Shares

$4.39 Billion
0.4% of portfolio
Primecap Management CO Pasadena, CA

39.9M
Shares

$3.56 Billion
2.42% of portfolio
Bank Of America Corp Charlotte, NC

32.6M
Shares

$2.92 Billion
0.18% of portfolio
Wellington Management Group LLP Boston, MA

32.3M
Shares

$2.89 Billion
0.45% of portfolio
Capital International Investors Los Angeles, CA

25.1M
Shares

$2.24 Billion
0.33% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account